Biosimilar Development solution center
-
Closing The Gap Between Modeling And GMP Predictive Control
11/10/2026
Predictive control offers opportunities to improve process consistency, reduce variability, and respond to changing manufacturing conditions before they cause deviations.
-
Can Peptide Mapping Predict Intact Antibody PTM Distributions?
11/2/2026
Peptide mapping quantifies modification at individual sites, but the same site-level results can correspond to different distributions across intact molecules.
-
How Does SUS Integrity Change Across The Drug Product Lifecycle?
9/24/2026
Learn how phase-appropriate risk justification, validation, documentation, and lifecycle controls can strengthen sterility assurance while reducing the potential for rework and delays.
-
Overview Of Single-Use System Integrity Assurance
9/24/2026
Single-use system integrity depends on managing risk across the entire life cycle. Explore how materials, packaging, transport, installation, handling, and use influence sterility assurance.
-
Can Targeted LNP Delivery Take In-Vivo CAR-T Therapy Beyond The Liver?
9/17/2026
Achieving successful extrahepatic CAR T delivery with LNPs requires addressing the unique biological and technological barriers and designing targeting approaches that leverage innovative LNP design.
-
Building Trust In AI For Computerized System Validation
9/4/2026
Using AI for CSV might feel like the students are grading their own papers. One consultant explains why it's not the same, namely, there are no subjective judgment calls.
-
A Gentler Cell Line Selection Method Using microRNA
9/4/2026
Traditional selection stresses surviving cells. New research shows how structurally interacting RNA may use endogenous microRNA for a faster, nontoxic selection process.
-
Developing Non-PEG Stabilizer Lipids For Nucleic Acid Lipid Nanoparticles
7/1/2026
Non-PEG stabilizer lipids may offer a new path for LNP design. Combining strong colloidal performance with greater chemical flexibility helps address growing concerns around PEG-related immunogenicity.
-
Neoantigen-Based Personalized Cancer Vaccine
7/1/2026
Personalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.
-
Lipid Nanoparticles For Pulmonary Delivery Of mRNA
7/1/2026
Gain insight into how nebulized mRNA lipid nanoparticles show preclinical success in lung delivery, offering fresh momentum for inhaled gene therapies targeting respiratory diseases.